Imetelstat Sodium Patent Expiration
Imetelstat Sodium was first introduced by Geron Corp
Imetelstat Sodium Patents
Given below is the list of patents protecting Imetelstat Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Rytelo | US9375485 | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms | Mar 15, 2033 | Geron |
| Rytelo | US7494982 | Modified oligonucleotides for telomerase inhibition | Dec 27, 2025 | Geron |
| Rytelo | US9388415 | Modified oligonucleotides for telomerase inhibition |
Sep 09, 2024
(Expired) | Geron |
| Rytelo | US9388416 | Modified oligonucleotides for telomerase inhibition |
Sep 09, 2024
(Expired) | Geron |
Imetelstat Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List